JERSEY CITY, N.J., July 24, 2024 /PRNewswire/ -- InsightAce Analytic
Pvt. Ltd. announces the release of a market assessment report on
the "ADME Toxicology Testing Market"- By Type of Services
(Absorption, Distribution, Metabolism, Excretion), Type of
Assays(Batch / Fed-Batch, Continuous), Type of Molecule
(Biologics, Small Molecules), End User(Pharmaceutical and
Biotechnology Companies, Academic / Research Institutes),
Therapeutic Areas(Blood Disorder, Cardiovascular Disorder,
Gastrointestinal and Vascular Disorder, Hormonal Disorder,
Infectious Diseases, Immunological Disorders, Mental Disorders,
Metabolic Disorders, Neurological Disorders, Oncology Disorders,
Respiratory Disorders), Industry Trends, and Global Forecasts,
2022-2035 And Segment Revenue and Forecast To 2031."
The ADME Toxicology Testing Market is estimated to reach
over USD 7.12 billion by 2031,
exhibiting a CAGR of 8.3% during the forecast period.
ADME is generally applied to investigate the impact of chemicals
on human health. Chemicals can be absorbed, distributed,
metabolized, or removed in biological systems in this manner.
Excretion is a method of eliminating some substances, but not all
of them. By considering every pathway a chemical takes as it
enters, passes through, and exits the body, human can determine its
toxicity. ADME is a crucial term in cellular biology and
biochemistry that defines the possible effects that a substance or
medication might have on a living organism. This is due to the fact
that a molecule's physicochemical characteristics and the host
system both affect its mobility and metabolism.
Free Download the Demo Report, Excel Pivot and ToC:
https://www.insightaceanalytic.com/request-sample/2596
Chemical characteristics include polarity, molecular weight,
molecular size, chirality, HOMO/LUMO, and many more have an effect
on the ADME potential of a molecule or toxin. ADME is typically
used to characterize a pharmaceutical compound's or drug's effects.
While ADME concepts are explicitly used in the design of drugs, no
rules pertaining to ADME are used in the design of chemicals
intended for commercial use.
Regulatory agencies, such as the FDA and EMA, have stringent
guidelines for drug safety and efficacy, necessitating
comprehensive ADME toxicology testing. Continuous advancements in
technologies, such as high-throughput screening, computational
modeling, and in vitro testing methods, enhance the efficiency and
accuracy of ADME toxicology testing.
List of Prominent Players in the ADME Toxicology
Testing Market:
- Thermo Fisher Scientific Inc.
- Promega Corporation
- Agilent Technologies, Inc.
- Charles River Laboratories
- RTI International
- Eurofins Scientific
- Evotec
- Galapagos
- Tecan Group
- GVK Biosciences
- Pharmaron
- Pharmaceutical Product Development (PPD)
- Sai Life Sciences
- Shanghai Medicilon
- Syngene International
- WuXi AppTec
ADME Toxicology Testing Market Report Scope:
Report
Attribute
|
Specifications
|
Market Size Value In
2023
|
USD 3.82 Bn
|
Market Size Value In
2031
|
USD 7.12 Bn
|
Growth rate
CAGR
|
CAGR of 8.3% from 2023
to 2031
|
Quantitative
units
|
Representation of
revenue in US$ Mn, and CAGR from 2024 to 2031
|
Historic
Year
|
2019 to 2023
|
Forecast
Year
|
2024-2031
|
Report
coverage
|
The forecast of
revenue, the position of the company, the competitive market
statistics, growth prospects, and trends
|
Segments
covered
|
By Type of Services,
Type of Assays, Type of Molecule, End User, Therapeutic
Areas
|
Regional
scope
|
North America; Europe;
Asia Pacific; Latin America; Middle East & Africa
|
Country
scope
|
U.S.; Canada; U.K.;
Germany; China; India; Japan; Brazil; Mexico; The UK; France;
Italy; Spain; China; Japan; India; South Korea; Southeast Asia;
South Korea; Southeast Asia
|
Market Dynamics:
Drivers:
The growth of the biopharmaceutical industry, which relies
heavily on ADME toxicology testing for biologics and biosimilars,
supports market expansion. Increasing investment by pharmaceutical
and biotechnology companies in research and development to discover
new drugs fuels the demand for ADME toxicology testing. The
increasing incidence of chronic diseases, such as cancer,
cardiovascular diseases, and diabetes, drives the need for new and
effective therapeutics, boosting the demand for ADME toxicology
testing. Growing awareness and emphasis on patient safety and drug
efficacy propel the demand for comprehensive ADME toxicology
testing throughout the drug development process.
Challenges:
The complexity of human biology and variability in responses to
drugs can make it challenging to accurately predict ADME properties
and toxicological effects, leading to potential inaccuracies. DME
toxicology testing is often expensive due to the need for
sophisticated equipment, advanced technologies, and highly skilled
personnel, which can limit accessibility for smaller companies and
research institutions.
Regional Trends:
North America dominates the
market during forecast. Leading adoption of advanced technologies
and methodologies in ADME testing, including high-throughput
screening and computational modeling. Compliance with stringent FDA
regulations drives demand for comprehensive ADME toxicology
testing. Significant investment in pharmaceutical and
biotechnological research and development drives the demand for
ADME toxicology testing. The rising prevalence of chronic and
infectious diseases drives the demand for new drugs, thereby
increasing the need for comprehensive ADME toxicology testing.
Asia Pacific is fastest growing
region. Rapidly growing pharmaceutical and biotechnology industries
in countries like China,
India, and Japan drive the demand for ADME testing
services. Rising investments in healthcare infrastructure and
research capabilities enhance regional market growth.
Curious about this latest version of the report? @
https://www.insightaceanalytic.com/enquiry-before-buying/2596
Recent Developments:
- In September 2023, Charles
River Laboratories agreed to a multi-program partnership agreement
with Related Sciences that covered medicinal chemistry, biology,
pharmacology, ADME, high-throughput screening, and finally safety
testing and IND submission. As part of the partnership, RS will
collaborate closely with the Charles River and Valo Health teams to
utilize Logica in the search for novel therapeutics that will
address important unmet needs in a variety of disease categories,
such as inflammatory disorders, cancer immunotherapy, and
autoimmune.
Segmentation of ADME Toxicology Testing
Market.
Global ADME Toxicology Testing Market -Type of
Services
- Absorption
- Distribution
- Metabolism
- Excretion
Global ADME Toxicology Testing Market – Type of Assays
- Batch / Fed-Batch
- Continuous
Global ADME Toxicology Testing Market – Type of
Molecules
- Biologics
- Small Molecules
Global ADME Toxicology Testing Market – End Users
- Pharmaceutical and Biotechnology Companies
- Academic / Research Institutes
Global ADME Toxicology Testing Market – Therapeutic
Areas
- Blood Disorder
- Cardiovascular Disorder
- Gastrointestinal and Vascular Disorder
- Hormonal Disorder
- Infectious Diseases
- Immunological Disorders
- Mental Disorders
- Metabolic Disorders
- Neurological Disorders
- Oncology Disorders
- Respiratory Disorders
North America-
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and
Africa
For More Customization @
https://www.insightaceanalytic.com/customisation/2596
Why should buy this report:
- To receive a comprehensive analysis of the prospects for global
ADME Toxicology Testing market
- To receive industry overview and future trends of global ADME
Toxicology Testing market
- To analyze the ADME Toxicology Testing market drivers and
challenges
- To get information on the ADME Toxicology Testing market size
value (US$ Mn) forecast till 2031
- Major Investments, Mergers & Acquisition in global ADME
Toxicology Testing industry
Other Related Reports Published by InsightAce
Analytic:
Genomic Cancer Testing Market
Testing, Inspection, and Certification Market
CT/NG Testing Market
Continuous Bioprocessing Market
Cytotoxic Drugs and HPAPI Manufacturing Market
About Us:
InsightAce Analytic is a market research and consulting firm
that enables clients to make strategic decisions. Our qualitative
and quantitative market intelligence solutions inform the need for
market and competitive intelligence to expand businesses. We help
clients gain competitive advantage by identifying untapped markets,
exploring new and competing technologies, segmenting potential
markets and repositioning products. Our expertise is in providing
syndicated and custom market intelligence reports with an in-depth
analysis with key market insights in a timely and cost-effective
manner.
Contact Us:
InsightAce Analytic PVT. LTD
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Follow us on LinkedIn:
https://www.linkedin.com/company/insightace-analytic-pvt-ltd/
Logo:
https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/adme-toxicology-testing-market-worth-7-12-billion-2031--reveals-by-insightace-analytic-pvt-ltd-study-302205208.html